Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 214

Results For "IMI"

3827 News Found

Integrated strategy needed to achieve 'TB Mukt Bharat'
Public Health | March 28, 2023

Integrated strategy needed to achieve 'TB Mukt Bharat'

Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis


Govt. reviews public health preparedness for management of COVID-19
Public Health | March 28, 2023

Govt. reviews public health preparedness for management of COVID-19

States advised to undertake mock drills to ensure operational readiness of Hospital Infrastructure including Oxygen Cylinders, PSA plants, ventilators and human resources


Lupin receives tentative approval from USFDA for Valbenazine capsules
Drug Approval | March 28, 2023

Lupin receives tentative approval from USFDA for Valbenazine capsules

Valbenazine Capsules (RLD Ingrezza) had estimated annual sales of USD 1,235 million in the U.S. (IQVIA MAT December 2022).


India ready to be voice of the global south in collaborative fight against TB: Dr. Mandaviya
Policy | March 27, 2023

India ready to be voice of the global south in collaborative fight against TB: Dr. Mandaviya

India has a pivotal role in eliminating TB


Briefs: Morepen Laboratories and Zydus Lifesciences
Drug Approval | March 27, 2023

Briefs: Morepen Laboratories and Zydus Lifesciences

The company is addressing these observations


Lupin announces completion of pharmacovigilance inspection by USFDA
Drug Approval | March 27, 2023

Lupin announces completion of pharmacovigilance inspection by USFDA

The inspection included a comprehensive scrutiny of practices and procedures for reporting of adverse events of Lupin’s marketed products worldwide


Lupin announces successful completion of UK MHRA inspection of Pithampur facilities
Drug Approval | March 27, 2023

Lupin announces successful completion of UK MHRA inspection of Pithampur facilities

With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility of the company


Quantumzyme receives patent for development of green catalyst in India
News | March 25, 2023

Quantumzyme receives patent for development of green catalyst in India

The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions


Zydus receives final approval from USFDA for Doxepin Hydrochloride Capsules USP, 150 mg
Drug Approval | March 25, 2023

Zydus receives final approval from USFDA for Doxepin Hydrochloride Capsules USP, 150 mg

Doxepin Hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety


Zydus receives final approval from USFDA for Lubiprostone Capsules, 8 mcg and 24 mcg
Drug Approval | March 25, 2023

Zydus receives final approval from USFDA for Lubiprostone Capsules, 8 mcg and 24 mcg

Lubiprostone capsule is indicated to treat certain types of constipation (chronic idiopathic constipation and irritable bowel syndrome with constipation)